Jing-Kang Shen - Search Results

Year	Number of Results
2003	1
2005	3
2006	2
2007	2
2008	1
2009	3
2010	3
2011	3
2012	4
2013	6
2014	2
2015	2
2016	4
2017	1
2018	1
2019	2
2020	2
2021	1
2023	1
2024	0

1

Epigenetics: novel therapeutics targeting epigenetics.

Conway SJ, Woster PM, Shen JK, Georg G, Wang S. Conway SJ, et al. Among authors: shen jk. J Med Chem. 2015 Jan 22;58(2):523-4. doi: 10.1021/jm501941q. Epub 2014 Dec 22. J Med Chem. 2015. PMID: 25532017 No abstract available.

2

AXL antibody and AXL-ADC mediate antitumor efficacy via targeting AXL in tumor-intrinsic epithelial-mesenchymal transition and tumor-associated M2-like macrophage.

Pei JP, Wang Y, Ma LP, Wang X, Liu L, Zhang Y, Jin R, Ren ZQ, Deng Y, Shen JK, Meng T, Yu K. Pei JP, et al. Among authors: shen jk. Acta Pharmacol Sin. 2023 Jun;44(6):1290-1303. doi: 10.1038/s41401-022-01047-6. Epub 2023 Jan 17. Acta Pharmacol Sin. 2023. PMID: 36650292

3

Discovery of MTR-106 as a highly potent G-quadruplex stabilizer for treating BRCA-deficient cancers.

Li MZ, Meng T, Song SS, Bao XB, Ma LP, Zhang N, Yu T, Zhang YL, Xiong B, Shen JK, Miao ZH, He JX. Li MZ, et al. Among authors: shen jk. Invest New Drugs. 2021 Oct;39(5):1213-1221. doi: 10.1007/s10637-021-01096-4. Epub 2021 Mar 12. Invest New Drugs. 2021. PMID: 33710464

4

[Progress in the fragment-based drug discovery].

Ren J, Li J, Shi F, Wang X, He JH, Xu YC, Zhang NX, Xiong B, Shen JK. Ren J, et al. Among authors: shen jk. Yao Xue Xue Bao. 2013 Jan;48(1):14-24. Yao Xue Xue Bao. 2013. PMID: 23600136 Review. Chinese.

5

New microtubulin inhibitor MT189 suppresses angiogenesis via the JNK-VEGF/VEGFR2 signaling axis.

Xu L, Wang W, Meng T, Ma LP, Tong LJ, Shen JK, Wang YQ, Miao ZH. Xu L, et al. Among authors: shen jk. Cancer Lett. 2018 Mar 1;416:57-65. doi: 10.1016/j.canlet.2017.12.022. Epub 2017 Dec 15. Cancer Lett. 2018. PMID: 29248713

6

Discovery of novel PTP1B inhibitors with antihyperglycemic activity.

Liu Z, Chai Q, Li YY, Shen Q, Ma LP, Zhang LN, Wang X, Sheng L, Li JY, Li J, Shen JK. Liu Z, et al. Among authors: shen jk. Acta Pharmacol Sin. 2010 Aug;31(8):1005-12. doi: 10.1038/aps.2010.81. Acta Pharmacol Sin. 2010. PMID: 20686525 Free PMC article.

7

A new BET inhibitor, 171, inhibits tumor growth through cell proliferation inhibition more than apoptosis induction.

Damaneh MS, Hu JP, Huan XJ, Song SS, Tian CQ, Chen DQ, Meng T, Chen YL, Shen JK, Xiong B, Miao ZH, Wang YQ. Damaneh MS, et al. Among authors: shen jk. Invest New Drugs. 2020 Jun;38(3):700-713. doi: 10.1007/s10637-019-00818-z. Epub 2019 Jul 3. Invest New Drugs. 2020. PMID: 31267379

8

[Research progress of sodium-glucose co-transporter 2 inhibitors for treatment of type 2 diabetes].

Wan HX, Shen JK. Wan HX, et al. Among authors: shen jk. Yao Xue Xue Bao. 2012 Jun;47(6):716-24. Yao Xue Xue Bao. 2012. PMID: 22919717 Review. Chinese.

9

Synthesis and bioassay of β-(1,4)-D-mannans as potential agents against Alzheimer's disease.

Jiang RW, Du XG, Zhang X, Wang X, Hu DY, Meng T, Chen YL, Geng MY, Shen JK. Jiang RW, et al. Among authors: shen jk. Acta Pharmacol Sin. 2013 Dec;34(12):1585-91. doi: 10.1038/aps.2013.104. Epub 2013 Nov 18. Acta Pharmacol Sin. 2013. PMID: 24241344 Free PMC article.

10

Inhibition of the BET family reduces its new target gene IDO1 expression and the production of L-kynurenine.

Tian CQ, Chen L, Chen HD, Huan XJ, Hu JP, Shen JK, Xiong B, Wang YQ, Miao ZH. Tian CQ, et al. Among authors: shen jk. Cell Death Dis. 2019 Jul 19;10(8):557. doi: 10.1038/s41419-019-1793-9. Cell Death Dis. 2019. PMID: 31324754 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

39 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Results by year